| 摘要 |
FIELD: medicine, pharmaceutics.SUBSTANCE: present invention refers to novel compounds specified in [1-(3,4-difluorobenzyl)-piperidin-4-yl]-(5-trifluoromethylpyridin-2-yl)amine, 6-{methyl-[1-(3-trifluoromethylbenzyl)-piperidin-4-yl]amino}nicotinonitrile, 6-[1-(3-trifluoromethylbenzyl)-piperidin-4-ylamino]nicotinonitrile, 6-[1-(3-fluoro-5-trifluoromethylbenzyl)-piperidin-4-ylamino]nicotinonitrile, 6-[1-(3,5-difluorobenzyl)-piperidin-4-ylamino]nicotinonitrile, 6-[1-(3,4,5-trifluorobenzyl)-piperidin-4-ylamino]nicotinonitrile, 2-{methyl-[1-(3-trifluoromethylbenzyl)piperidin-4-yl]amino}isonicotinonitrile, 6-[1-(3-fluoro-5-trifluoromethylbenzyl)piperidin-4-ylamino]pyridin-2-carbonitrile, (1-benzyl-piperidin-4-yl)-(5-trifluoromethylpyridin-2-yl)amine, 6-[1-(3,5-difluorobenzyl)piperidin-4-ylamino]-pyridin-2-carbonitrile; 6-[1-(3,4,5-trifluorobenzyl)piperidin-4-ylamino]-pyridin-2-carbonitrile and 6-(1-benzyl-piperidin-4-ylamino)-pyridin-2-carbonitrile, to their pharmaceutically acceptable salts and stereoisomer forms used as antipsychotic agents, as well as to a based pharmaceutical composition.EFFECT: preparing the compounds used as antipsychotic agents.3 cl, 11 ex |
